Evidence map›Paper›PMID 40322665›Full record

ArticleInternational journal of women's health2025

Rare Case Report: Coexistence of Complete Hydatidiform Mole and Normal Fetus in a Twin Pregnancy.

Ping Li, XiuPing Liu

Abstract readCase Reports
In one paragraph

Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ping LiObstetrics and Gynecology Department of the Hebei Medical University Third Hospital, Shijiazhuang, People's Republic of China.
XiuPing LiuObstetrics and Gynecology Department of the Hebei Medical University Third Hospital, Shijiazhuang, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coexistence of a complete hydatidiform mole with a normal fetus in a twin pregnancy is a rare, high-risk obstetric condition with an extremely low incidence rate, presenting numerous clinical management challenges. The rarity of such cases, coupled with the scarcity of comprehensive literature, makes the successful management of this case a source of valuable experience and novel insights for clinical practice. Case Presentation: A 32-year-old patient conceived following a clomiphene-induced ovulation regimen. Mid-pregnancy ultrasound indicated a twin pregnancy (one viable fetus, the other consistent with the appearance of a complete hydatidiform mole), and the patient chose to continue the pregnancy. At 36+4 weeks of gestation, the patient was admitted for pregnancy-induced hypertension and underwent a cesarean section, delivering a healthy female infant and simultaneously removing the molar tissue. Postoperative pathological examination confirmed a complete hydatidiform mole with invasive lesions, which progressed to an invasive hydatidiform mole. The patient underwent seven cycles of methotrexate combination chemotherapy, with a follow-up period of three years showing no recurrence, ensuring the health of both mother and child. Conclusion: Managing twin gestations involving a complete hydatidiform mole and a normal fetus necessitates a multidisciplinary approach, grounded in individualized assessment. The successful treatment of this case demonstrates that standardized diagnosis, close postoperative follow-up, and chemotherapy are crucial factors in improving maternal and fetal outcomes, offering significant clinical reference value.

Indexed as

chemotherapycomplete hydatidiform moleindividualized managementpregnancy-induced hypertensiontwin pregnancy

Identifiers

PMID40322665
PMCPMC12047649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.